Navigation Links
Researchers and Patient Advocates Honored with PhRMA Award
Date:9/7/2012

WASHINGTON, Sept. 7, 2012 /PRNewswire-USNewswire/ -- The Pharmaceutical Research and Manufacturers of America (PhRMA) announced today the recipients of the first annual Research and Hope Awards. This year's award honors outstanding achievements in academia, the biopharmaceutical research sector, as well as the patient and caregiving communities to help advance medical progress and patient care for Alzheimer's disease.

"Too often, the hard work and unwavering commitment by individuals who dedicate their lives to improving patient care go unrecognized. The Research and Hope Award honors those who rightly deserve credit for all of the sacrifices they have made to advance research and patient care in the fight against Alzheimer's disease," said PhRMA President and CEO John J. Castellani. "Despite the tremendous hurdles, the recipients of the Award have shown us that progress is not only possible, it is happening every day. Their achievements give hope to all of us, especially to patients and their families."

Alzheimer's disease is a progressive brain disease that slowly destroys memory and thinking skills, affecting one in eight older Americans. Current projections show that by 2050, one American will develop the disease every 33 seconds, costing the U.S. health care system $1.1 trillion annually. During that time, Alzheimer's related Medicare spending alone will increase nearly 600 percent. These projections could change dramatically if a treatment were discovered to help delay the onset of Alzheimer's by five years. Such a treatment could help save Medicare and Medicaid $140 billion annually in 2030, and could save the U.S. health care system $447 billion annually by 2050, according to the Alzheimer's Association.

"On behalf of PhRMA and our member companies, we salute these award recipients for their heroic work to advance medical research and improve patient care," said John C. Lechleiter, PhD, chairman, president, and chief executive officer of Eli Lilly and Company and chairman of PhRMA.   "The individuals whom we honor with the Research and Hope Awards, through their achievements, highlight the importance of our collaborative efforts to bring forth new medicines that alleviate suffering, improve lives, and bring hope for people around the world."

The researcher awardees were chosen by a special committee of the PhRMA Foundation Board of Directors following a nominations process. The patient advocate recipients were selected by a committee consisting of representatives from PhRMA and the cohost organizations.

The nominations were reviewed and discussed at length and chosen by a group of individuals with extensive knowledge and experience in the science and patient advocacy fields. 

The full list of awardees is below:

The Research and Hope Award for Academic Research in Alzheimer's:

Bradley T. Hyman, MD, PhD
Professor of Neurology
Massachusetts General Hospital/Harvard Medical School

David Holtzman, MD
Andrew B. and Gretchen P. Jones Professor and Chairman
Department of Neurology, Washington University School of Medicine

The Research and Hope Award for Biopharmaceutical Industry Research in Alzheimer's: Merck BACE Team

Eric M. Parker, PhD
Senior Director and Neuroscience Site Lead, Merck

Andrew W. Stamford, PhD
Director, Discovery Chemistry, Merck

Matthew E. Kennedy, PhD
Associate Director, Neuroscience, Merck

Mark S. Forman, MD, PhD
Director, Clinical Research, Merck

Julie A. Stone, PhD
Senior Scientific Director, Merck

The Research and Hope Award for Patient Engagement:

Kate Maslow
Institute of Medicine
Keck Center

The Research & Hope Award for Volunteer Champion: 

Neha Chauhan 
AFA Teens for Alzheimer's Awareness

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $49.5 billion in 2011 in discovering and developing new medicines.

Find PhRMA Online:

For information on how innovative medicines save lives, visit: http://www.innovation.org 
For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org 
For information on ensuring the flow of medicines during public health emergencies, visit http://www.rxresponse.org


'/>"/>
SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Researchers Set Record for Detecting Smallest Virus, Opening New Possibilities for Early Disease Detection
2. Latest Breakthroughs and Treatments in Spinal Cord Injury Medicine Bring Top Clinicians and Researchers Together in Las Vegas
3. Researchers Discover All-Natural Weapon In The War Against Ovarian Cancer
4. Researchers Developing New Multiple Sclerosis Drug That Can Be Taken Orally
5. Aethlon Medical (AEMD) Note: Cancer Treatment Publication Authored by Aethlon Medical Researchers Now Available
6. Researchers Evaluate Computer-based Treatment for People with Schizophrenia
7. Van Andel Institute Researchers Find Potential Drug Target For Aggressive Form Of Lymphoma
8. Rethinking Research Ethics: Carnegie Mellon and McGill Researchers Challenge Post-marketing Trial Practices
9. The SFJ Pharmaceuticals Group Announces Agreement With Pfizer to Co-develop Dacomitinib as First-Line Treatment for Patients With Advanced Non-small Cell Lung Cancer
10. Actinium Pharmaceuticals Commences Screening for the Second Cohort of Patients in the Companys Ongoing Phase I/II Trial in Acute Myeloid Leukemia
11. NxStage Submits Formal Comments to CMS to Improve Patient Access to Life-changing More Frequent Home Hemodialysis Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
(Date:6/24/2016)... 24, 2016 According to a ... (Standard Pen Needles, Safety Pen Needles), Needle Length (4mm, ... Hormone), Mode of Purchase (Retail, Non-Retail) - Trends & ... studies the market for the forecast period of 2016 ... 2.81 Billion by 2021 from USD 1.65 Billion in ...
(Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing ... their videos a whole new perspective by using the title layers in ProSlice ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/26/2016)... , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal ... personalized through a fitness app. The fitness app plans to fix the two major problems ... offer a one size fits all type program , They don’t eliminate all ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
Breaking Medicine News(10 mins):